Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer
NCT00197431
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
OTHER
Sponsor class
Conditions
Gastric Cancer
Esophageal Cancer
Pancreatic Cancer
Colon Cancer
Interventions
DRUG:
S-1
Sponsor
Hamamatsu University